Delivery Order SPE2DB24D8002-SPE2DB25FJNUN
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This delivery order was placed under Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,262.22 firm-fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S, with a period of performance ending on May 22, 2025. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $8,785.43 and a performance period ending on June 17, 2024. Dakota Drug, Inc. has also been awarded a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 under the DLA Troop Support Medical's ECAT Generation V Program,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $8,499.18, is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 held by Dakota Drug, Inc. This IDC allows...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, valued at $8,358.56, is a firm fixed-price delivery order for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award has an ultimate completion date of February 11, 2025. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,272.41 fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of October 19, 2023. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQXN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,834.67 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through May 13, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a substantial...